Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques

Author(s):
Velstra, B.; Vonk, M.A.; Bonsing, B.A.; Mertens, B.J.; Nicolardi, S.; Huijbers, A.; Vasen, H.; Deelder, A.M.; Mesker, W.E. (0000-0001-5533-4778); Burgt, Y.E.M. van der (0000-0003-0556-5564); Tollenaar, R.A.E.M. (0000-0002-6831-6082)
Published
2015
Publication type
Article / Letter to editor
ScreeningMALDI-TOFBiomarker signatureProteomicsClinical decision making
Date issued
2015-03-31
Language
English
Is part of
Journal of Cancer Research and Clinical Oncology (2015), Vol. 141, no. 3, p. 531-541
hdl
1887/117233
doi
10.1007/s00432-014-1812-2